The 2-Minute Rule for Conolidine Proleviate for Joint Pain Treatment
Conolidine’s analgesic results stem from its interaction with non-opioid pain pathways. Compared with opioids, which bind to µ-opioid receptors inside the central anxious system, conolidine modulates alternate molecular targets. A Science Advancements study found that conolidine interacts While using the atypical chemokine receptor ACKR3/CXCR7,